ABC
NVO

Associated Banc-Corp’s Novo Nordisk NVO Stock Holding History

Associated Banc-Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,367
Closed -$204K – 329
2024
Q4 		$204K Sell
2,367
-203
-8% -$22K 0.01% 310
2024
Q3 		$306K Sell
2,570
-80
-3% -$10.7K 0.01% 282
2024
Q2 		$378K Buy
2,650
+370
+16% +$49K 0.01% 258
2024
Q1 		$293K Hold
2,280
– – 0.01% 274
2023
Q4 		$236K Hold
2,280
– – 0.01% 289
2023
Q3 		$207K Buy
+2,280
New +$201K 0.01% 291
2021
Q1 		– Sell
-226
Closed -$8K – 675
2020
Q4 		$8K Hold
226
– – ﹤0.01% 453
2020
Q3 		$8K Hold
226
– – ﹤0.01% 425
2020
Q2 		$7K Hold
226
– – ﹤0.01% 417
2020
Q1 		$7K Buy
+226
New +$6.73K ﹤0.01% 408

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Associated Banc-Corp's NVO Position: Q1 2025 in Review

Associated Banc-Corp sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,367 shares — an estimated $204K sold.

Associated Banc-Corp first reported a position in NVO in Q1 2020 and held it in 10 quarters. The position peaked at $378K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Associated Banc-Corp reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Associated Banc-Corp sold 2,367 Novo Nordisk shares in Q1 2025, an estimated $204K.
  • Associated Banc-Corp first reported a position in Novo Nordisk in Q1 2020 and held it in 10 quarters.
  • Associated Banc-Corp's Novo Nordisk position peaked at $378K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Associated Banc-Corp's 13F filing for Q1 2025, filed 9 May 2025.